PREVALENCE OF PERSISTENT LIPID ABNORMALITIES IN HIGH-RISK PATIENTS TREATED WITH STATINS: RESULTS OF THE DYSLIPIDEMIA INTERNATIONAL STUDY IN THE UK

被引：0
|
作者：
Kotseva, K. [1 ]
Bowker, T. [2 ]
Jennings, C. [1 ]
Turner, E. [3 ]
Amber, V. [1 ]
Wood, D. [1 ]
机构：
[1] Imperial Coll London, Natl Heart & Lung Inst, London, England
[2] Homerton Univ Hosp NHS Trust, Dept Cardiol, London, England
[3] London Sch Hyg & Trop Med, Dept Epidemiol & Publ Hlth, London WC1, England
来源：
HEART | 2010年 / 96卷
关键词：
D O I：
10.1136/hrt.2010.196089.11
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A68 / A68
页数：1
相关论文
共 50 条
  • [31] Prevalence of dyslipidemia in statin-treated patients in the Baltic states (Estonia, Latvia, and Lithuania): Results of the Dyslipidemia International Study (DYSIS)
    Viigimaa, Margus
    Erglis, Andrejs
    Latkovskis, Gustavs
    Maeeots, Ene
    Petrulioniene, Zaneta
    Slapikas, Rimvydas
    Gocentiene, Anete
    Bramlage, Peter
    Brudi, Philippe
    MEDICINA-LITHUANIA, 2014, 50 (01): : 44 - 53
  • [32] LIPID PROFILE OF SPANISH PATIENTS WITH CORONARY HEART DISEASE TREATED WITH STATINS. THE DYSLIPIDEMIA INTERNATIONAL STUDY (DYSIS-SPAIN)
    Millan, J.
    Gonzalez-Juanatey, J. R.
    Guijarro, C.
    Alegria, E.
    Lozano, J. V.
    Gonzalez-Timon, B.
    Vitale, G.
    ATHEROSCLEROSIS SUPPLEMENTS, 2010, 11 (02) : 159 - 159
  • [33] Persistent lipid abnormalities in statin-treated patients: Portuguese diabetic subpopulation of the Dyslipidaemia International Study (DYSIS)
    da Silva, Pedro Marques
    Cardoso, Salvador Massano
    Ferreira, Antonio Miguel
    PRIMARY CARE DIABETES, 2015, 9 (04) : 283 - 289
  • [34] THE CURRENT STATUS OF LIPID CONTROL IN ELDERLY HIGH-RISK PATIENTS WITH DYSLIPIDEMIA IN TAIWAN
    Liang, C. -H.
    Chang, Y. -H.
    Tsai, C. -L.
    Chuang, J. -Y.
    Hsiao, C. -C.
    Zeng, Y. -H.
    Chen, Y. -H.
    Yeh, H. -I.
    Lin, C. -F.
    ATHEROSCLEROSIS, 2022, 355 : E195 - E196
  • [35] Results of the Dyslipidemia International Study (DYSIS)-Middle East: Clinical Perspective on the Prevalence and Characteristics of Lipid Abnormalities in the Setting of Chronic Statin Treatment
    Al Sifri, Saud N.
    Almahmeed, Wael
    Azar, Sami
    Okkeh, Osama
    Bramlage, Peter
    Juenger, Claus
    Halawa, Islam
    Ambegaonkar, Baishali
    Wajih, Sameh
    Brudi, Philippe
    PLOS ONE, 2014, 9 (01):
  • [36] Prevalence and Characteristics of Lipid Abnormalities in Patients Treated With Statins in Primary and Secondary Prevention in Spain. DYSIS-Spain Study
    Gonzalez-Juanatey, Jose R.
    Millan, Jesus
    Alegria, Eduardo
    Guijarro, Carlos
    Lozano, Jose V.
    Vitale, Gustavo C.
    REVISTA ESPANOLA DE CARDIOLOGIA, 2011, 64 (04): : 286 - 294
  • [37] Predominant types of dyslipidemia in patients with coronary heart disease treated with statins in Europe and Canada: data from the dyslipidemia international study
    Gitt, A. K.
    Kastelein, J. P. P.
    EUROPEAN HEART JOURNAL, 2009, 30 : 591 - 591
  • [38] Factors influencing dyslipidemia in statin-treated patients in Lebanon and Jordan: results of the Dyslipidemia International Study
    Azar, Sami T.
    Abu Hantash, Hadi
    Jambart, Selim
    El-Zaheri, Mohamed M.
    Rachoin, Rachoin
    Chalfoun, Amal
    Lahoud, Layla
    Okkeh, Osama
    Bramlage, Peter
    Brudi, Philippe
    Ambegaonkar, Baishali M.
    VASCULAR HEALTH AND RISK MANAGEMENT, 2014, 10 : 225 - 235
  • [39] CARDIOVASCULAR RISK PREVALENCE IN HIGH RISK PRIMARY CARE PATIENTS NOT TREATED WITH LIPID-LOWERING TREATMENT IN FRANCE, RESULTS OF AN ONLINE STUDY
    Kownator, S.
    Ferrieres, J.
    Bruckert, E.
    Bonnelye, G.
    Thomas-delecourt, F.
    Delaage, P. H.
    Dallongeville, J.
    VALUE IN HEALTH, 2012, 15 (07) : A345 - A345
  • [40] Lipid-lowering therapy with statins in high-risk elderly patients - The treatment-risk paradox
    Ko, DT
    Mamdani, M
    Alter, DA
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (15): : 1864 - 1870
12345